Thermo Fisher Scientific (TMO) Total Current Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Current Liabilities for 18 consecutive years, with $14.6 billion the latest figure, recorded in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $14.6 billion, up 10.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.6 billion (up 10.98% YoY), and the FY2025 annual result was $15.2 billion, up 13.93% from the prior year.
• Total Current Liabilities was $14.6 billion for Q1 2026 at Thermo Fisher Scientific, down from $15.2 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $17.0 billion in Q4 2022 and troughed at $11.0 billion in Q3 2022.
• Average Total Current Liabilities over 5 years is $13.9 billion, with a median of $14.1 billion recorded in 2023.
• Year-over-year, Total Current Liabilities surged 72.55% in 2022 and declined 17.62% in 2023.
• Over 5 years, Total Current Liabilities stood at $17.0 billion in 2022, then retreated by 17.62% to $14.0 billion in 2023, then slipped by 4.85% to $13.3 billion in 2024, then gained by 13.93% to $15.2 billion in 2025, then slipped by 3.74% to $14.6 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $14.6 billion in Q1 2026, $15.2 billion in Q4 2025, and $14.9 billion in Q3 2025.